AbelsonTaylor
Independent
Address
433 W Van Buren
Chicago, Illinois 60607
Web Address
Year Founded
1981
North American Revenue
$64,811,000
Full-time Employees
278
Number of Clients
22
North American Revenue 2021
Full-time Employees 2021
Number of clients 2021
Offices
North America
1
Locations
Chicago, IL
Executives & Senior Management
Dale Taylor
Chairman & CEO
Jeff Berg
President
Jay Carter
EVP, Director of Business Development
Senior Management
Dale Taylor
Chairman and CEO
Jeff Berg
President
Jay Carter
EVP, Director of Business Development
Stephen Neale
EVP, Chief Creative Officer
Lynnette Hunter
EVP, Director of Client Services
Jeanine Koch
EVP, Director of Project Management
Keith Stenlund
EVP, CFO
Agency 100 Book Cover
Capabilities/Services Offered
Professional
Consumer
OTC
Direct Marketing
Media Planning
Med-Tech
Data/Analytics
Digital
New Services
We hired Yolanda Macias as our first Director of Diversity and Inclusion
Created a formal DEI mission
Addressed Employee Centricity, Psychological Safety, Communication Systems, DEI Training and Awareness,
Addressed Diverse Representation
Established a partnership with The Equality Institute.
Client Roster
Amgen - Enbrel Arcutis Biotherapeutics
ARQ-151 Astellas Pharma US Inc.
Mycamine
AmBisome
Avanos - Coolief
Chiesi
Bethkis
Bronchitol
Cardene IV
Curosurf
Pertzye
Cleviprex
Kengreal
Retavase
City of Hope - Cancer Center
CooperSurgical - EndoSee
CSL Behring
AFSTYLA
Haegarda
Hizentra
Humate-P
Idelvion
Kcentra
Privigen
Berinert
Synfugo
CSL312
EtranaDez
Mononine
Plasma
VWD
G1 Therapeutics - Cosela
Kodiak - KSI-301
MetaMe Health - Regulora
Neurocrine Biosciences - Ingrezza
Pharmacosmos - Monoferric
Pharmavite - Equelle
Seres Therapeutics - SER-109
Sunovion Pharmaceuticals Inc. - Latuda
Takeda Pharmaceuticals North America Inc.
Dexilant
Motegrity
Natpara
Gattex
Vericel
Maci
Nexobrid
Growth
2021 Growth from Existing Clients
23%
2021 Growth from New Clients
13%
Projections
Our stated goal for growth was 15% and we achieved it.
Trends and Challenges
Diversity and inclusion
Talent acquisition/retention
Managing growth
Payer-related challenges
Pricing-related issues
Getting an audience, virtually or otherwise, with HCPs
Keeping up with pace of innovation
Procurement-related issues
Shrinking pharma budgets
Further diversification of services
Pandemic-related disruptions
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Increased concern over drug pricing
Industry consolidation
Scrutiny around social media
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Decreased impact of sales forces
Regulatory changes
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Working from home
Ongoing fallout from pandemic
Ongoing fallout from societal unrest
Creative Samples
